Extended-Release Pseudoephedrine Trial Results “Positive,” SCOLR Says
This article was originally published in The Tan Sheet
Executive Summary
The first of three human studies evaluating SCOLR Pharma's extended-release pseudoephedrine tablets has shown "positive" initial results, the company announced March 28